Organovo Holdings Inc’s recent filing unveils that its Director Gobel David unloaded Company’s shares for reported $31750.0 on Nov 15 ’23. In the deal valued at $1.62 per share,19,607 shares were sold. As a result of this transaction, Gobel David now holds 0 shares worth roughly $0.0.
H.C. Wainwright initiated its Organovo Holdings Inc [ONVO] rating to a Buy in a research note published on December 13, 2018; the price target was $2.50. A number of analysts have revised their coverage, including Raymond James’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Mkt perform”. Raymond James began covering ONVO with “an Outperform” recommendation on January 25, 2017. Cantor Fitzgerald revised its rating on August 11, 2015. It rated ONVO as “a Hold” which previously was an “a Buy”.
Price Performance Review of ONVO
On Friday, Organovo Holdings Inc [NASDAQ:ONVO] saw its stock jump 8.38% to $1.03. Over the last five days, the stock has gained 3.00%. Organovo Holdings Inc shares have fallen nearly -7.21% since the year began. Nevertheless, the stocks have fallen -44.62% over the past one year. While a 52-week high of $2.05 was reached on 04/15/24, a 52-week low of $0.89 was recorded on 02/09/24. SMA at 50 days reached $1.0357, while 200 days put it at $1.1964. A total of 1.11 million shares were traded, compared to the trading of 88200.0 shares in the previous session.
Levels Of Support And Resistance For ONVO Stock
The 24-hour chart illustrates a support level at 0.9300, which if violated will result in even more drops to 0.8300. On the upside, there is a resistance level at 1.1500. A further resistance level may holdings at 1.2700. The Relative Strength Index (RSI) on the 14-day chart is 49.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0695, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.97%. Stochastics %K at 9.87% indicates the stock is a buying.
The most recent change occurred on June 29, 2015 when Piper Jaffray began covering the stock and recommended ‘”an Overweight”‘ rating along with a $5 price target.
